ATHE
NASDAQ
$4.74
Alterity Therapeutics Ltd (ATHE)
Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinson's disease and other neurodegenerative diseases in Australia. The company is headquartered in Melbourne, Australia.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $12.67 (+167.30%)
Market Cap
$85M
Revenue 5Y CAGR
+111.91%
Free Cash Flow Yield
-24.37%
Beta (5Y)
1.04
Price Chart
Valuation
Market Cap$85M
P/S13.60
P/B2.46
Profitability
Total Revenue (TTM)$4.16M
Gross Profit (TTM)$4.32M
EBITDA-$21M
Profit Margin-219.9%
Operating Margin-372.6%
EPS-$1.41
Financial Health
Debt-to-Equity0.2%
Free Cash Flow Yield-24.37%
Growth & Risk
Revenue 5Y CAGR+111.91%
FCF 5Y CAGR+19.72%
Beta (5Y)1.04
Sharpe Ratio0.32